Kidney Transplant ISS Flashcards

1
Q

need for one or more hd within 1st week

A

DGF -FUNCAO TARDIA DO ENXERTO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

moderate early graft dysfunction, plasma crea > 3 at 1 week post kt

A

• Allograft function: If a new transplant, is there

immediate graft functioncreat <2,5 dentro de 5 dias

or SGF (Slow graft function) creat >2,5 ate o 5 dia

versus

DGF (Delayed Graft Function, means requiring HD in less than 1 weeks), this is impacted by donor factors, cold ischemia time (>24 hrs), intra-op issues, and patient issues including ischemiareperfusion (warm ischemia time > 45 min).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

rejection occuring 2-5 days after transplant

A

Accelerated rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

important risk factor for dgf c

A

cold ischemia time

fatores de risco =

DOADOR= idade, vivo ou falecido, doador padrao, criterio expandido

RECEPTOR= homem, imc>30, negro, dialise, diabetes, HLA imunizacao

tx=tempo de isquemia quente, tempo de isquemia frio, solucao de armazenamento,maquina de perfusoa ou n

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

high risk patients with rejection symptoms

A

biopsy day 3-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

low risk patients

A

biopsy day 7-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tx of acute abmr

A

pulse, plasmapharesis, ivig, rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mild/moderate tcmr

A

Steroid pulse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Severe tcmr mgt

A

steroid pulse:thymoglobuling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

high cni levels

A

Cyclosporine > 350
tacrolimus > 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

common adverse effect of mmf and tacrolimus

A

diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

renal artery or vein thrombosis occurs in the

A

1st 72h-10 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

most common cause of allograft function in the first week

A

acute vascular thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

abrupt onset of anuria, rapidly rising crea, negligible graft pain, absent arterial and venous blood flow, MR absent perfusion

A

renal artery thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

anuria pain tenderness swelling hematuria, absent renal venous blood flow and highly abnormal renal arterial waveforms, mr thrombus in the vein

A

renal vein thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

failure of impvt in urine output or plasma crea within 5 days of pulse

A

steroid resistant tcmr
tx depleting antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

tcmr resistant to tx witg antilymphocytic antibody

A

refractory tcell mediated rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

standard target levels of cyclosporine

A

C0 150-300, 100-200
C2 1400-1700, 800-1299

19
Q

standard level tacrolimus

A

C0 8-12, 6-9

20
Q

initial measure in transplant tma

A

switch cni
dc cni, start belatacept or mtor
pex
eculizumab

21
Q

most common microorganism acute pyelo post kt

A

Gram neg, cons, enterococci

22
Q

most common dryg causing ain

A

smx tmp

23
Q

best radiologic technique for determining site of obstruction

A

percutaneous antegrade pyelography

24
Q

Drugs that increase cni level

A

ccb
antifungal
antidepressant
grapefruit

25
Q

decrease cni level

A

nafcillin
tb meds
efvires nevirapine
antiseizure meds
st johns

26
Q

plasma viral titers of bk nephropathy

A

> 10^4

27
Q

tx of bk

A

discontinue mmf
redcue cni by 30-50

28
Q

chronic active abmr tx

A

switch to tacro-mmf
target tacro 8
minim mmf
low dose pred
ace/arv

29
Q

striped cortical fibrosis or new onset arteriolar hyalinosis with microcalcification

A

cni toxicity

30
Q

Gout post kt

A

cyclosporine
tx colchicine and steroids

31
Q

post kt electrolyte do

A

hyperCa
hypophos
hyperK
met acid
hypoMg
hyperparathyroid

32
Q

osteoporosis bone density greater than

A

2.5SD below the mean
osteopenia 1-2.5

33
Q

antihtn agrnts in transplant
chf, post mi, cad

A

bblocker and ace/arb
no bblocker in htn and proteinuria only

34
Q

high intensity statin recommended for > 21 with

A

ascvd
ldl > 190
persons 40-75 with dn and est 10 yr risk > 7.5

35
Q

no increased risk ca

A

breast prostate rectum

36
Q

high sir ca

A

kaposi with hiv

37
Q

poor prognosis ptld

A

monoclonal

38
Q

considerations in kt in hiv

A

cd4 txell > 200
undetectable hiv rna

39
Q

Pregnancy considerations post kt

A

good health more than 18 mos
stable allograft function
crea less than 2
minimal htn and proteinuria

40
Q

indications for allograft nephrectomy

A
  1. allograft failure symptomatic
  2. infarction due to thrombosis
  3. severe infection
  4. allograft rupture
41
Q

Relative contraindication to donation

A

2 apol1 renal risk variants
chronic illness
type 2 dm
morbid obesity
active substance use disorder

42
Q

dados importantes sobre o doador

A

Relevant donor data: age, sex, size, KDPI score, initial/peak/terminal creatinine, HIV/Hep C status urine output, biopsy, relevant history (DM/HTN) Cold and warm ischemia time (preferred cold ischemia time (CIT) is <24 hours and warm ischemia time (WIT) is <45 minutes) Public Health Service (PHS) high risk: yes or no (risk factors include prisoner, history of drug use, sex worker, etc) CMV and EBV status of donor and recipient HLA cross match and if Donor Specific Antibody (DSA) was present Induction therapy Removal of ureteral stent and dialysis catheter (usually to be scheduled post-op so if no date can put to be scheduled) Relevant surgical details if there were intra-operative complications

43
Q
A
44
Q

transplante duplo figado e rim

A

ira por mais de 6 semas com mais um criterio

  • dialise
  • tfg<25

tfg<60 por mais de 90 dias com : eskd, tfg<30

doenca metabolica